Strasser et al., 2023 - Google Patents
Degradable bottlebrush polypeptides and the impact of their architecture on cell uptake, pharmacokinetics, and biodistribution in vivoStrasser et al., 2023
View PDF- Document ID
- 9809214305256854011
- Author
- Strasser P
- Montsch B
- Weiss S
- Sami H
- Kugler C
- Hager S
- Schueffl H
- Mader R
- Brüggemann O
- Kowol C
- Ogris M
- Heffeter P
- Teasdale I
- Publication year
- Publication venue
- Small
External Links
Snippet
Bottlebrush polymers are highly promising as unimolecular nanomedicines due to their unique control over the critical parameters of size, shape and chemical function. However, since they are prepared from biopersistent carbon backbones, most known bottlebrush …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
- A61K47/48192—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes
- A61K47/48215—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer, dendrimer, e.g. PEG, PPG, PEO, polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
- A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/002—Dendritic macromolecules
- C08G83/003—Dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guillaudeu et al. | PEGylated dendrimers with core functionality for biological applications | |
| Jiang et al. | Poly (N‐phenylglycine)‐Based nanoparticles as highly effective and targeted near‐infrared photothermal therapy/photodynamic therapeutic agents for malignant melanoma | |
| Wang et al. | Fabrication of pH-responsive nanoparticles with an AIE feature for imaging intracellular drug delivery | |
| Guo et al. | Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy | |
| Reichert et al. | Size‐Dependant Cellular Uptake of Dendritic Polyglycerol | |
| Qu et al. | A nanoplatform with precise control over release of cargo for enhanced cancer therapy | |
| Cong et al. | Tuning the brightness and photostability of organic dots for multivalent targeted cancer imaging and surgery | |
| Strasser et al. | Degradable bottlebrush polypeptides and the impact of their architecture on cell uptake, pharmacokinetics, and biodistribution in vivo | |
| Santra et al. | Aliphatic hyperbranched polyester: a new building block in the construction of multifunctional nanoparticles and nanocomposites | |
| Xiong et al. | Amphiphilic polycarbonates from carborane-installed cyclic carbonates as potential agents for boron neutron capture therapy | |
| Ding et al. | Hyperbranched conjugated polyelectrolyte for dual‐modality fluorescence and magnetic resonance cancer imaging | |
| Hu et al. | Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug | |
| Liu et al. | DACHPt-loaded unimolecular micelles based on hydrophilic dendritic block copolymers for enhanced therapy of lung cancer | |
| Lee et al. | Supramolecular assembly based on host–guest interaction between beta-cyclodextrin and adamantane for specifically targeted cancer imaging | |
| Ranucci et al. | Polyamidoamines: Versatile bioactive polymers with potential for biotechnological applications | |
| Chen et al. | Synthesis and properties of star-comb polymers and their doxorubicin conjugates | |
| Rastogi et al. | Dendrimer as nanocarrier for drug delivery and drug targeting therapeutics: a fundamental to advanced systematic review | |
| CN111712524B (en) | Para-dihydroxyboryl phenylalanine derivatives and compositions containing same, and kits for preparing same | |
| An et al. | An acid-triggered degradable and fluorescent nanoscale drug delivery system with enhanced cytotoxicity to cancer cells | |
| CN102302782A (en) | Preparation method of hepatoma carcinoma cell-targeted polyamido-amine dendrimer support | |
| Jeong et al. | A cancer‐recognizing polymeric photosensitizer based on the tumor extracellular pH response of conjugated polymers for targeted cancer photodynamic therapy | |
| Cao et al. | Biodegradable nanoglobular magnetic resonance imaging contrast agent constructed with host–guest self-assembly for tumor-targeted imaging | |
| US10155050B2 (en) | Cross-linked star-shaped self-assembled polypeptides and its use as carriers in biomedical applications | |
| Zu et al. | Development of an aptamer-conjugated polyrotaxane-based biodegradable magnetic resonance contrast agent for tumor-targeted imaging | |
| Allcock et al. | Tyrosine-bearing polyphosphazenes |